Felix Pharma: Ledger

Stories naming Felix Pharma. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Felix Pharma is not recorded as having acquired anything.

Funding announcement

Advent to buy majority stake in NZCR Group in ANZ healthcare deal

Advent International is to take a majority holding in trans-Tasman clinical trials operator NZCR, whose existing backers, among them Waterman Capital, will keep a minority position, with a fourth-quarter close anticipated.

DealStreetAsia 20 Aug 2026 Advent Cohance Felix Pharma New Zealand Clinical Research Group Simtra Waterman Capital Tony Moffatt

Also adventinternational.com·nzcr.co.nz·biospectrumasia.com·healthcaredealflow.com

Felix Pharma

Funding history

Investors

What Felix Pharma bought

People

Coverage

Advent to buy majority stake in NZCR Group in ANZ healthcare deal